BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11036111)

  • 1. Predicting the cumulative risk of false-positive mammograms.
    Christiansen CL; Wang F; Barton MB; Kreuter W; Elmore JG; Gelfand AE; Fletcher SW
    J Natl Cancer Inst; 2000 Oct; 92(20):1657-66. PubMed ID: 11036111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
    Burman ML; Taplin SH; Herta DF; Elmore JG
    Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year risk of false positive screening mammograms and clinical breast examinations.
    Elmore JG; Barton MB; Moceri VM; Polk S; Arena PJ; Fletcher SW
    N Engl J Med; 1998 Apr; 338(16):1089-96. PubMed ID: 9545356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age and breast density on screening mammograms with false-positive findings.
    Lehman CD; White E; Peacock S; Drucker MJ; Urban N
    AJR Am J Roentgenol; 1999 Dec; 173(6):1651-5. PubMed ID: 10584815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening.
    Román R; Sala M; Salas D; Ascunce N; Zubizarreta R; Castells X
    Ann Oncol; 2012 Jan; 23(1):104-111. PubMed ID: 21430183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
    Castells X; Molins E; Macià F
    J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing women's anxieties after abnormal mammograms: a controlled trial.
    Barton MB; Morley DS; Moore S; Allen JD; Kleinman KP; Emmons KM; Fletcher SW
    J Natl Cancer Inst; 2004 Apr; 96(7):529-38. PubMed ID: 15069115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits.
    Barton MB; Moore S; Polk S; Shtatland E; Elmore JG; Fletcher SW
    J Gen Intern Med; 2001 Mar; 16(3):150-6. PubMed ID: 11318909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of false-positive mammograms on return for subsequent screening mammography.
    Pinckney RG; Geller BM; Burman M; Littenberg B
    Am J Med; 2003 Feb; 114(2):120-5. PubMed ID: 12586231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening.
    Román R; Sala M; De La Vega M; Natal C; Galceran J; González-Román I; Baroja A; Zubizarreta R; Ascunce N; Salas D; Castells X
    Breast Cancer Res Treat; 2011 Nov; 130(2):543-52. PubMed ID: 21617920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer.
    Lampic C; Thurfjell E; Sjödén PO
    Eur J Cancer; 2003 Aug; 39(12):1730-7. PubMed ID: 12888368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening.
    Lipkus IM; Halabi S; Strigo TS; Rimer BK
    Psychooncology; 2000; 9(5):402-10. PubMed ID: 11038478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening mammograms by community radiologists: variability in false-positive rates.
    Elmore JG; Miglioretti DL; Reisch LM; Barton MB; Kreuter W; Christiansen CL; Fletcher SW
    J Natl Cancer Inst; 2002 Sep; 94(18):1373-80. PubMed ID: 12237283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of first mammography examination in women younger than 40 years.
    Yankaskas BC; Haneuse S; Kapp JM; Kerlikowske K; Geller B; Buist DS;
    J Natl Cancer Inst; 2010 May; 102(10):692-701. PubMed ID: 20439838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.
    Dabbous FM; Dolecek TA; Berbaum ML; Friedewald SM; Summerfelt WT; Hoskins K; Rauscher GH
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):397-403. PubMed ID: 28183826
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening mammography for frail older women: what are the burdens?
    Walter LC; Eng C; Covinsky KE
    J Gen Intern Med; 2001 Nov; 16(11):779-84. PubMed ID: 11722693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing misclassification of hormone users at mammography screening.
    Njor SH; Pedersen AT; Schwartz W; Hallas J; Lynge E
    Int J Cancer; 2009 May; 124(9):2159-65. PubMed ID: 19132752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
    Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
    J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance With Screening Mammography Guidelines After a False-Positive Mammogram.
    Hardesty LA; Lind KE; Gutierrez EJ
    J Am Coll Radiol; 2016 Sep; 13(9):1032-8. PubMed ID: 27233908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.